Madison Avenue Partners, LP Keros Therapeutics, Inc. Transaction History
Madison Avenue Partners, LP
- $1.09 Billion
- Q3 2025
A detailed history of Madison Avenue Partners, LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Madison Avenue Partners, LP holds 2,708,218 shares of KROS stock, worth $46.7 Million. This represents 3.92% of its overall portfolio holdings.
Number of Shares
2,708,218
Previous 2,691,465
0.62%
Holding current value
$46.7 Million
Previous $35.9 Million
19.24%
% of portfolio
3.92%
Previous 3.85%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
169Shares Held
35.4MCall Options Held
574KPut Options Held
325K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$93 Million8.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.72MShares$46.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$43.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.19MShares$37.8 Million10.27% of portfolio
-
Tang Capital Management LLC San Diego, CA1.42MShares$24.5 Million1.02% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $445M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...